Today, Médecins Sans Frontiès released data on their experience treating patients with multi-drug resistant and extensive drug resistant tuberculosis in Tuberculosis: Fighting a Losing Battle.
[…] 45 percent died, did not improve with treatment, or defaulted because of side effects, isolation, and other difficulties in tolerating the treatment.
Below is a ten-minute documentary on the emergence of these forms of tuberculosis that focuses on the role of Partners in Health.
Médecins Sans Frontiès has an informative article on tuberculosis that includes many good links. Last November, Yale released information on the link between HIV/ AIDS and extensively drug-resistant tuberculosis.
Médecins Sans Frontiès and Partners in Health both carry four star ratings from Charity Navigator.
A brief search of Charity Navigator turned up the Seattle Biomedical Research Institute with four stars. They’ve a team specializing in drug resistance in tuberculosis and other bacteria.
We worry about multi-drug resistance because untreated it’s a death sentence,
– Dr Paul Nunn,
WHO